| Financial Year |
March 31 2022 |
| Monetary Funds |
42,031,496.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
13,632,211.18 |
| Advances to Suppliers |
29,063,937.41 |
| Other Receivables |
266,094.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
113,135,002.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,000,548.00 |
| Total Current Assets |
207,129,290.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
437,376.09 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
304,982.95 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
12,779,671.97 |
| Total Assets |
219,908,962.58 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,281,116.80 |
| Accounts Received In Advance |
756,000.00 |
| Employee Compensation Payable |
857,174.94 |
| Taxes Payable |
2,883,424.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
175,742,233.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,998,148.89 |
| Other Current Liabilities |
1,074,135.99 |
| Sub-Total of Current Liabilities |
201,527,078.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
594,960.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,494,650.03 |
| Total Liabilities |
205,021,728.81 |
| Paid-In Capital(Or Share Stock) |
523,199,665.00 |
| Capital Surplus |
2,286,807,231.75 |
| Surplus Reserve |
55,004,947.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,873,372,101.72 |
| Minority Stockholder's Interest |
5,897,426.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,989,807.57 |
| Owner's Equity（Stockholder's Equity） |
14,887,233.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
219,908,962.58 |
